• Clinical and Experimental Pediatrics
• /
• v.51 no.5
• /
• pp.457-461
• /
• 2008

Kawasaki disease (KD) was first described by Dr. Tomisaku Kawasaki in his 1975 study, published in Pediatrics. Its pathogenesis is still not clearly understood. Early diagnosis and treatment are very important to preventing concomitant coronary artery complications. Most KD patients respond well to the standard treatment of aspirin and intravenous immunoglobulin; however, some of them are refractory to the standard treatment, and so adjuvant therapies with corticosteroids and anti-tumor necrosis $factor-{\alpha}$ ($TNF-{\alpha}$) antibody are necessary. In this article, the author reviews and summarizes the most recent literature on the treatment of refractory KD.

• The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology
• /
• v.20 no.2 s.33
• /
• pp.213-229
• /
• 2007

Objective : This study investigated results of treatment of Atopic Dermatitis(AD) patients diagnosed as damp-heat type with herbal medicine and wet dreesing. Method : Six AD subjects diagnosed as damp-heat type were selected from the outpatient department of East-West Neo Medical Center in the period of Dec. 2006 to Feb. 2007. Each subject was treated with herbal medicine and wet dressing. Severity Scoring of Atopic Dermatitis(SCORAD) was used to evaluate the effect of treatment and pictures were taken of the Atopic dermatitis lesions. Result & Conclusion : We observed improvement on SCORAD score, especially intensity score of damp-heat type when they were treated with herbal medicine and wet dressing. However, it is less effective and AD often recurs in case of chronic adult-type AD. In addition, nipple eczema in some patients has showed a tendency to improve slowly and recur easily compared to other lesions.

• The Journal of Korean Medicine
• /
• v.23 no.4
• /
• pp.9-14
• /
• 2002

To assess the clinical efficacy of Chungpyesagan-tang on acute stroke, we prescribed this medicine to 88 acute stroke patients without thrombolytic treatment. The rate of progressive stroke type was 2.3%, remarkably lower than in previous reports. 1.1 % felt an itching sensation, and 17.0% complaxined of loose stool and diarrhea. Chungpyesagan-tang decreased Stroke-Pattern Identification and National Institute of Health Stroke Scale (NIHSS), and increased Modified Barthel Index (MBI). Thus, we could suggest that this medicine has a desirable effect to reduce the severity of stroke and improve functional recovery. As to the laboratory findings, ALT had anupward tendency and increased over normal value in 16 cases (18.2%). However, the mean serum level 2 weeks later was within the normal value and the other hepatic enzymes did not increase.

• The Journal of Korean Medicine
• /
• v.25 no.1
• /
• pp.111-116
• /
• 2004

Objective : To assess the clinical efficacy of Yangkyuksanwha-tang on acute stroke Methods : We prescribed Yangkyuksanwha-tang to 83 acute stroke patients without thrombolytic treatment. Results : The rate of progressive stroke type was 1.2%, it was remarkably lower than previous reports. 3.6% felt an itching sensation, 3.6% complained headache, dizziness and powerless, 2.4% complained indigestion and diarrhea, 1.2% appeared hematuria and G-I bleeding. Yangkyuksanwha-tang decreased Stroke-Pattern Identification and National Institute of Health Stroke Scale(NIHSS), and increased Modified Barthel Index(MBI). So we could suggest that this medicine have desirable effect to reduce the severity of stroke and improve functional recovery. As to the laboratory findings, all results were within the normal value, which showed no hepatic or renal toxicity. Conclusion : We could suggest that Yangkyuksanwha-tang is a useful medicine which has clinical efficacy for acute stroke, but further investigation for an administration of more than 2 weeks is necessary.

• The Journal of Internal Korean Medicine
• /
• v.25 no.4
• /
• pp.318-323
• /
• 2004

Objectives : The purpose of this clinical study is to evaluate the clinical efficacy of Pasaekhwalhyeol-Tang on acute headache from acute cerebral infarct. Methods : Pasaekhwalhyeol-Tang was prescribed to 15 acute cerebral infarct patients for two weeks. Symptoms were checked and VAS(Visual Analog Scale) scores were kept every week. Results : After prescription of Pasaekhwalhyeol-Tang, VAS scores on headache and accompanying symptoms decreased. No significant changes were shown in laboratory findings. As for the laboratory findings, ALT showed an upward tendency within a week and increased over normal values in two cases(13%). But two weeks later, ALT decreased within normal values. And the mean serum level was within normal values and the other hepatic enzymes did not increase over normal values in either week nor week 2. Conclusions : Results suggest that Pasaekhwalhyeol-Tang is effective in reducing the severity of acute headache from acute cerebral infarct.

• Proceedings of the KAIS Fall Conference
• /
• 2010.05b
• /
• pp.579-581
• /
• 2010

2007년1월1일부터 12월 31일까지 퇴원환자조사에서 제외되었던, 100병상미만 의료기관을 조사대상으로 선정하였다. 퇴원환자조사를 위해 조사 기반자료인 의무기록을 토대로 손상퇴원환자의 일반적 특성, 진료비지불방법, 질병 및 수술 양상과 의료이용 실태를 파악하였다. 2007년 한 해동안 전국 100병상미만의 급성기 의료기관을 퇴원한 추정 환자수는 총 4,697,095명으로 이는 전체 인구의 9.7%에 해당 한다. 인구 10만명당 퇴원율은 9,693명이며 평균재원일수는 9.8일이었다. 퇴원후 귀가한 퇴원환자수는 전체 4,538,861명이었고 이중 남성은 1,784,041명, 여성은 2,754,821명이었다. 타병원으로 이송된 환자는 119,378명이었으며 의뢰병원으로 회송된 환자도 8,970명 이었다.

• The Journal of Korean Medicine
• /
• v.19 no.1
• /
• pp.385-391
• /
• 1998

Stroke is badly demaged for patient, family, society and country. To reduce a sequelae and return rapidly to society, treatment at acute stages is very important. In the research on xiafa(下法;diarrhea technique) used at the acute stages of stroke, the results were as follows. On the treatment of stroke, we are to control qi(氣) For it, sweeting technique(汗法), vomitting technigue(吐法) and diarrhea technique(xiafa ;下法) are used. For treatment on biaoshizheng(標實 reyufushi, 熱鬱腑實) at acute stages, tongfuxiexiafa(通腑瀉下法) is in general use. At acute stages, mental state is very important. Therefore, Xiafa(下法) have to conduct by zangfu(臟腑)'s law. At the acute stages, xiafa(下法) improved a whole body problems by treatment on a constipation and dysuria. We think that xiafa(下法) clinically effect on the cerebral edema and increased intracranial pressure. In the future, experimental study is needed.

• Korean Journal of Acupuncture
• /
• v.37 no.3
• /
• pp.191-197
• /
• 2020

This case study reports the clinical response to Korean Medicine (KM) treatments including capsaicin-containing (CP) pharmacopuncture in three patients with acute low back and hip pain. Three patients were diagnosed with acute lumbar sprain, and were treated with CP pharmacopuncture, and other KM treatments including acupuncture, cupping, and herbal medicine. Numeric Rating Scale (NRS), Oswestry Disablility Index (ODI), and Clinical Evaluation Grade (CEG) were used to evaluate symptom changes. After one or two treatments, acute pain with limited range of motion in the low back and thigh region improved with a decrease in NRS, ODI, and CEG. These results suggest that further studies on KM treatments including CP pharmacopuncture for acute low back and hip pain are warranted.

• Proceedings of the Korean Information Science Society Conference
• /
• 2010.06c
• /
• pp.410-413
• /
• 2010

병원정보시스템의 전세계적인 보급과 데이터웨어하우스의 도입으로 인해서 병원내의 의료데이터가 기하 급수적인 증가추세를 보이고 있다. 환자에 대한 임상적인 특징을 다수 포함하고 있는 의료데이터는 유용한 임상지식의 보고로서 그 가치가 매우 유용하다. 따라서 데이터에 숨겨진 지식을 발견하여 구조화시킴으로써 새로운 지식을 창조하는 데이터마이닝은 임상부분에 적합한 기술이라 말할 수 있다. 본 연구에서는 급성염증을 가진 환자들의 의료데이터를 기반으로 특징을 추출하고, 추출된 특징을 바탕으로 병명을 판단하기 위한 학습을 수행한다. 학습 방법은 클러스터링을 이용한 나이브 베이지안으로 진행한다. 기존의 나이브 베이지안 학습은 대량의 데이터를 처리하는데 효과적이며 성능 또한 우수하지만, 속성별 독립을 가정하기 때문에 의료데이터를 분석에는 잘 사용되지 않는다. 따라서 높은 신뢰도를 구현하기 위해 나이브 베이지안 학습 전에 클러스터링을 선행하여, 기존 데이터에 클러스터링 클래스를 추가한다. 이를 통해 급성염증의 증상을 보이는 환자데이터를 바탕으로 자동적으로 방광염과 결석으로 인한 신장염을 효과적으로 진단해낸다.

• Journal of Chest Surgery
• /
• v.30 no.11
• /
• pp.1077-1082
• /
• 1997

To assess the early results, risk factors and optimal timing for coronary artery bypass graft surgery(CABG) after an acute myocardial infarction(AMI), we reviewed our 19 patients who underwent CABG within 30 days after AMI, between June 1994 and October 1996. This study excluded 1 patient whose diagnosis was AMI with ventricular septal rupture. 14 of the patients were male and 5 were female. Their ages ranged from 41 to 77 years(mean age, 60.6$\pm$ 10.4 years), and the amount of time between AMI and CABG ranged from 8 hours to 24 days(mean time, 10.6$\pm$6.4 days). There were 11 anteroseptal infarctions and 8 inferior wall infarctions. 11 patients had trsnsmural infarctions and 8 had subendocardial infarctions. Indications of operations were p imary revascularization and postinfarction angina. Three patients required preoperative intra-aortic balloon pump(IABP) support, and 4 additional patients required IABP to be separated from cardiopulmonary bypass. An average of 3.6 $\pm$ 0.6 vessels per patient were bypassed. The early mortality rate for these 19 patients was 5.3% and late mortality rate was 5.5%, 1-year and 2-year actuarial survival rates were 89.5% Univariate analysis of mortality showed that an ejection fraction less than 30% and intraopretative IABP supports were associated with risk factors(p value=0.018 and 0.015 respectively). Age, sex, time to CABG, emergency operations, types and locations of infarctions were not significant. Although our studies have weak p.oints in that there was only a small number of patients and the lack of long-term results, we could conclude that early myocardial revascularization is relatively safe after AMI for those individuals with an ejection fraction greater than 30%.